Trials / Conditions / Advanced Malignant Cancer
Advanced Malignant Cancer
6 registered clinical trials studyying Advanced Malignant Cancer — 4 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Clinical Trial of TQB3205 Capsule in Subjects With Advanced Malignant Tumors NCT07482592 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Phase 1 |
| Recruiting | A Clinical Trial on the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of TQB3019 Capsule in NCT06943677 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Phase 1 |
| Not Yet Recruiting | A Clinical Trial of TQB3117 Tablets in Patients With Advanced Malignant Cancer NCT06415903 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Phase 1 |
| Not Yet Recruiting | Phase I Study of SHR-2022 Injection in the Treatment of Patients With Advanced Malignant Tumors NCT06131216 | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Phase 1 |
| Withdrawn | Phase I Study of HRS-7053 Injection in the Treatment of Patients With Advanced Malignancies NCT05983146 | Jiangsu HengRui Medicine Co., Ltd. | Phase 1 |
| Completed | A Study of SHR-A1909 in Subjects With Advanced Malignant Tumors NCT05162469 | Shanghai Hengrui Pharmaceutical Co., Ltd. | Phase 1 |